{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:19:37Z","timestamp":1791476377837,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":238,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.vaccine.2023.01.017","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T07:25:12Z","timestamp":1673853912000},"page":"1554-1566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vaccine properties of Brucella melitensis 16M\u0394wzm and reactivation of placental infection in pregnant sheep"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4609-4933","authenticated-orcid":false,"given":"A.","family":"Zabalza-Barangu\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2784-7426","authenticated-orcid":false,"given":"I.","family":"Poveda-Urkixo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-055X","authenticated-orcid":false,"given":"S.","family":"Mena-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-1378","authenticated-orcid":false,"given":"G.A.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"De Bolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1819-0186","authenticated-orcid":false,"given":"M.J.","family":"Grill\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.01.017_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of B. melintesis Rev1 vaccine in adult aheep and goats","volume":"31","author":"Blasco","year":"1997","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2023.01.017_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriy\u00f3n","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2023.01.017_b0015","unstructured":"OIE. Chapter 3.1.4: Brucellosis (Brucella abortus, B. melitensis and B. suis) Infection with B. abortus, B. melitensis and B. suis. Off. Int. Epizoot. World Organ. Anim. Heal. Man. Diagnostic Tests Vaccines Terr. Anim., 2018."},{"key":"10.1016\/j.vaccine.2023.01.017_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front Biol (Beijing)"},{"key":"10.1016\/j.vaccine.2023.01.017_b0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vetimm.2016.02.002","article-title":"A review of the basis of the immunological diagnosis of ruminant brucellosis","volume":"171","author":"Ducrotoy","year":"2016","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0030","doi-asserted-by":"crossref","unstructured":"Valvano MA. Genetics and biosynthesis of lipopolysaccharide, vols. 1\u20133. Elsevier Ltd; 2014. https:\/\/doi.org\/10.1016\/B978-0-12-397169-2.00004-4.","DOI":"10.1016\/B978-0-12-397169-2.00004-4"},{"key":"10.1016\/j.vaccine.2023.01.017_b0035","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.vaccine.2005.12.038","article-title":"Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS\/bvrR and rough wbkA mutants","volume":"24","author":"Grill\u00f3","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.017_b0040","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.71.6.3261-3271.2003","article-title":"Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model","volume":"71","author":"Monreal","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.01.017_b0045","doi-asserted-by":"crossref","first-page":"e2760","DOI":"10.1371\/journal.pone.0002760","article-title":"Brucellosis vaccines: Assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export","volume":"3","author":"Gonz\u00e1lez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.017_b0050","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.vaccine.2009.01.025","article-title":"Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep","volume":"27","author":"Barrio","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.017_b0055","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1016\/j.vaccine.2008.07.030","article-title":"Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections","volume":"26","author":"Adone","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.017_b0060","doi-asserted-by":"crossref","first-page":"e24073","DOI":"10.1371\/journal.pone.0024073","article-title":"Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18","volume":"6","author":"Adone","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.017_b0065","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1099\/00221287-138-6-1211","article-title":"O-chain expression in the rough Brucella melitensis strain B115: Induction of O-polysaccharide-specific monoclonal antibodies and intracellular localization demonstrated by immunoelectron microscopy","volume":"138","author":"Cloeckaert","year":"1992","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0923-2508(00)90130-X","article-title":"Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of Brucella melitensis 16M (wbk)","volume":"151","author":"Godfroid","year":"2000","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0075","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2014.01.070","article-title":"Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep","volume":"32","author":"P\u00e9rez-Sancho","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.017_b0080","first-page":"33","article-title":"The degree of protection given by living vaccines against experimental infection with Brucella melitensis in goats","volume":"34","author":"Morgan","year":"1966","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2023.01.017_b0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature25190","article-title":"Architecture of a channel-forming O-antigen polysaccharide ABC transporter","volume":"553","author":"Bi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.01.017_b0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2741\/1079","article-title":"Export of O-specific lipopolysaccharide","volume":"8","author":"Valvano","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.vaccine.2023.01.017_b0095","first-page":"13","article-title":"Brucella melitensis Wzm\/Wzt system: changes in the bacterial envelope lead to improved Rev1\u0394wzm vaccine properties","author":"Mena-Bueno","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/mmi.13589","article-title":"CtrA controls cell division and outer membrane composition of the pathogen Brucella abortus","volume":"103","author":"Francis","year":"2017","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0105","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the National Center for Biotechnology Information (NCBI)","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2023.01.017_b0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2023.01.017_b0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-1119(97)00453-8","article-title":"Isolation and characterization of the UDP-glucose 4\u2019-epimerase-encoding gene, galE, from Brucella abortus 2308","volume":"202","author":"Scupham","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2023.01.017_b0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/tbed.13053","article-title":"GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep","volume":"66","author":"Zabalza-Barangu\u00e1","year":"2019","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2023.01.017_b0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0003-2697(82)90673-X","article-title":"A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels","volume":"119","author":"Tsai","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2023.01.017_b0130","unstructured":"Alton G, Jones L, Angus R, Verger J. Techniques for the brucellosis laboratory. 1988."},{"key":"10.1016\/j.vaccine.2023.01.017_b0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/biol.2000.0249","article-title":"In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines","volume":"28","author":"Grill\u00f3","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2023.01.017_b0140","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/infdis\/jit007","article-title":"Pathogenic brucellae replicate in human trophoblasts","volume":"207","author":"Salcedo","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.017_b0145","doi-asserted-by":"crossref","unstructured":"Rehbinder C, Alenius S, Bures J, de las Heras M, Greko C, Kroon PS, et al. Felasa recommendations for the health monitoring of experimental units of calves, sheep and goats. Report of the Federation of European Laboratory Animal Science Associations (FELASA) working group on animal health. Lab Anim 2000;34:329\u201350. https:\/\/doi.org\/10.1258\/002367700780387723.","DOI":"10.1258\/002367700780387723"},{"key":"10.1016\/j.vaccine.2023.01.017_b0150","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The arrive guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-014-0072-0","article-title":"Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice","volume":"45","author":"Soler-Llor\u00e9ns","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2023.01.017_b0160","doi-asserted-by":"crossref","unstructured":"Poveda-Urkixo I, Ram\u00edrez GA, Grill\u00f3 MJ. Kinetics of placental infection by different smooth Brucella strains in mice. Pathogens 2022;11. https:\/\/doi.org\/10.3390\/pathogens11030279.","DOI":"10.3390\/pathogens11030279"},{"key":"10.1016\/j.vaccine.2023.01.017_b0165","doi-asserted-by":"crossref","unstructured":"EMEA\/CVMP\/VICH\/359665\/2005. VICH Topic GL44 Step 7: Guideline on target animal safety for veterinary live inactivated vaccines. Section 2.2. Reproductive Safety Test. Eur Med Agency Defin 2009. https:\/\/doi.org\/10.32388\/yokp53.","DOI":"10.32388\/YOKP53"},{"key":"10.1016\/j.vaccine.2023.01.017_b0170","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1128\/JCM.02301-10","article-title":"Development of a selective culture medium for primary isolation of the main Brucella species","volume":"49","author":"De Miguel","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0175","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01759-22","article-title":"BruSIC: a novel selective medium for the primary isolation of Brucella in veterinary samples","author":"Mena-Bueno","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2023.01.017_b0180","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/JCM.01860-09","article-title":"Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp","volume":"48","author":"Lonsway","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4315\/0362-028X-48.6.532","article-title":"A review of effects of carbon dioxide on microbial growth and food quality","volume":"48","author":"Daniels","year":"1985","journal-title":"J Food Prot"},{"key":"10.1016\/j.vaccine.2023.01.017_b0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/AEM.65.2.626-631.1999","article-title":"Effect of compressed carbon dioxide on microbial cell viability","volume":"65","author":"Debs-Louka","year":"1999","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1286-4579(00)01359-9","article-title":"TNF-\u03b1 and IL-12: a balancing act in macrophage functioning","volume":"3","author":"Ma","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.01.017_b0200","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/IAI.72.4.2429-2433.2004","article-title":"Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence","volume":"72","author":"Jim\u00e9nez de Bag\u00fc\u00e9s","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.01.017_b0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevImmunol.v26.i5.30","article-title":"Host immune responses to the intracellular bacteria Brucella: Does the bacteria instruct the host to facilitate chronic infection?","volume":"26","author":"Baldwin","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0210","first-page":"239","article-title":"Rough Brucella neotomae provides protection against Brucella suis challenge in mice","author":"Jain-Gupta","year":"2019","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2180-5-22","article-title":"Interferon-\u03b3 promotes abortion due to Brucella infection in pregnant mice","volume":"5","author":"Kim","year":"2005","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0220","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/jiaa722","article-title":"Administration of exogenous progesterone protects against Brucella abortus infection-induced inflammation in pregnant mice","volume":"224","author":"Ren","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.01.017_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-45-61","article-title":"Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection","volume":"45","author":"Sancho","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2023.01.017_b0230","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.vaccine.2009.10.073","article-title":"Evaluation of particulate acellular vaccines against Brucella ovis infection in rams","volume":"28","author":"Da Costa","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.017_b0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/030098589303000204","article-title":"Placental pathology of the pregnant mouse inoculated with Brucella abortus strain 2308","volume":"30","author":"Tobias","year":"1993","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0034-5288(92)90107-D","article-title":"Comparative behaviour of Brucella abortus strains 19 and RB51 in the pregnant mouse","volume":"53","author":"Tobias","year":"1992","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2023.01.017_b0245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tvjl.2013.12.021","article-title":"A pregnant mouse model for the vertical transmission of Brucella melitensis","volume":"200","author":"Wang","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2023.01.017_b0250","first-page":"8","article-title":"Heat shock cognate protein 70 contributes to Brucella invasion into trophoblast giant cells that cause infectious abortion","author":"Watanabe","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0255","first-page":"120","article-title":"Vaccine candidate Brucella melitensis 16M\u0394vjbR is safe in a pregnant sheep model and confers protection","volume":"5","author":"Hensel","year":"2020","journal-title":"Ther Prev"},{"key":"10.1016\/j.vaccine.2023.01.017_b0260","first-page":"205","article-title":"Responses of ewes to B. melitensis Rev1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy","volume":"20","author":"Jim\u00e9nez de Bag\u00fc\u00e9s","year":"1989","journal-title":"Ann Rech Vet"},{"key":"10.1016\/j.vaccine.2023.01.017_b0265","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.vaccine.2008.03.030","article-title":"Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams","volume":"26","author":"Mu\u00f1oz","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.01.017_b0270","first-page":"536","article-title":"Vacunaci\u00f3n de ovejas lactantes con Rev1 por v\u00eda conjuntival","volume":"16","author":"P\u00e9rez","year":"1995","journal-title":"ITEA"},{"key":"10.1016\/j.vaccine.2023.01.017_b0275","first-page":"69","article-title":"Notes from the field: Brucella abortus RB51 infections associated with consumption of raw milk from Pennsylvania-2017 and 2018","author":"Gruber","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.01.017_b0280","first-page":"177","article-title":"Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev 1 vaccine: Safety and serological responses","volume":"23","author":"Zundel","year":"1992","journal-title":"Ann Rech Vet"},{"key":"10.1016\/j.vaccine.2023.01.017_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0185823","article-title":"Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1","volume":"12","author":"Higgins","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.017_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-019-0717-0","article-title":"Brucella melitensis Rev. 1 vaccination generates a higher shedding risk of the vaccine strain in Alpine ibex (Capra ibex) compared to the domestic goat (Capra hircus)","volume":"50","author":"Ponsart","year":"2019","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2023.01.017_b0295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jac\/dkl289","article-title":"Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB\/c mice","volume":"58","author":"Grill\u00f3","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2023.01.017_b0300","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/AAC.30.6.958","article-title":"Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis","volume":"30","author":"Ariza","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2023.01.017_b0305","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1389201014666131226123016","article-title":"Research progress in live attenuated Brucella vaccine development","volume":"14","author":"Wang","year":"2013","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0310","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.micinf.2014.06.013","article-title":"Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate","volume":"16","author":"Wang","year":"2014","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.01.017_b0315","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0034-5288(98)90135-7","article-title":"Evaluation of rough mutant of Brucella melitensis in pregnant goats","volume":"64","author":"Elzer","year":"1998","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2023.01.017_b0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vetmic.2003.10.024","article-title":"Intracellular trafficking study of a RB51 B. abortus vaccinal strain isolated from cow milk","volume":"98","author":"Arellano-Reynoso","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0325","first-page":"10","article-title":"Brucella: reservoirs and niches in animals and humans","author":"Gonz\u00e1lez-Espinoza","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2023.01.017_b0330","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1471-4922(02)02324-3","article-title":"Neospora caninum: a cause of immunemediated failure of pregnancy?","volume":"18","author":"Quinn","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2023.01.017_b0335","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0167-5699(97)01127-4","article-title":"Th1-type immunity is incompatible with successful pregnancy","volume":"18","author":"Raghupathy","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2023.01.017_b0340","doi-asserted-by":"crossref","unstructured":"Verger JM, Grayon M, Zundel E, Lechopier P, Olivier-Bernardin V. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Elsevier Sci Ltd 1995;19:191\u20136. https:\/\/doi.org\/10.20506\/rst.20.3.1305.","DOI":"10.1016\/0264-410X(95)93135-V"},{"key":"10.1016\/j.vaccine.2023.01.017_b0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.prevetmed.2018.01.005","article-title":"A systematic review of current immunological tests for the diagnosis of cattle brucellosis","volume":"151","author":"Ducrotoy","year":"2018","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2023.01.017_b0350","doi-asserted-by":"crossref","first-page":"e0260288","DOI":"10.1371\/journal.pone.0260288","article-title":"Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle","volume":"16","author":"Chac\u00f3n-D\u00edaz","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.01.017_b0355","series-title":"Polarity of envelope growth and heterogeneity of the outer membrane of Brucella abortus","author":"Vassen","year":"2018"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:22:42Z","timestamp":1759404162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0264410X23000282"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine properties of Brucella melitensis 16M\u0394wzm and reactivation of placental infection in pregnant sheep","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}